A contract research organisation (CRO) is a service provider organisation that provides different drug development and clinical data management services to the pharmaceutical and biotechnology sectors that are involved in clinical trials (for both drugs and medical devices). CROs are classified as major, medium, small, or specialised speciality groups. In order to strengthen their market position, key industry players are focused on inorganic development techniques such as mergers and acquisitions. The key elements that are predicted are price fluctuations and the hidden cost of clinical research services will limit the market growth throughout the forecast period. Furthermore, with the increased use of technical platforms, such as software for clinical data management, database management, document management, and others, extra expenditures are included in the services. The use of such modern technology improves the whole process and delivers quality data; nevertheless, it raises the cost of outsourcing services, which is likely to impede the growth of the contract research organisation (CROs) market in the United States over the forecast period.
According to Coherent Market Insights, U.S. Contract Research Organization (CROs) Market is estimated to be valued at US$ 15,918.6 million in 2022 and is expected to exhibit a CAGR of 9.6% during the forecast period (2022-2030). Some of the companies highlighted by Coherent Market Insights are:
Top Companies in the U.S. Contract Research Organization (CROs) Industry
1. Laboratory Corporation of America Holdings (Covance)